-
Product Insights
Insulin Resistance Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Insulin Resistance Global Clinical Trials Review, H2, 2017" provides an overview of Insulin Resistance clinical trials scenario. This report provides top line data relating to the clinical trials on Insulin Resistance. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
Type 2 Diabetes: Competitive Landscape to 2026
Type 2 Diabetes (T2D) is a chronic disease characterized by insulin resistance and pancreatic β-cell failure, with an underlying genetic predisposition heavily influenced by diet and lifestyle. Insulin is a hormone that regulates the glucose level in blood. Raised blood sugar (hyperglycemia) is an immediate consequence of diabetes, and over time leads to serious tissue damage, affecting the heart, blood vessels, eyes, kidneys, and nerves. This report provides an assessment of the pipeline, clinical, and commercial landscape of T2D. Overall,...
-
Product Insights
Non-Proliferative Diabetic Retinopathy (NPDR) Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Non-Proliferative Diabetic Retinopathy (NPDR) Global Clinical Trials Review, H1, 2018" provides an overview of Non-Proliferative Diabetic Retinopathy (NPDR) clinical trials scenario. This report provides top line data relating to the clinical trials on Non-Proliferative Diabetic Retinopathy (NPDR). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Pompe Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Pompe Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Pompe Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Pompe Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides...
-
Product Insights
Diabetic Foot Infection (DFI) - Global Clinical Trials Review, H1, 2021
GlobalData's clinical trial report, “Diabetic Foot Infection (DFI) - Global Clinical Trials Review, H1, 2021" provides an overview of Diabetic Foot Infection (DFI) Clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Foot Infection (DFI). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status...
-
Product Insights
Hyperinsulinemia - Global Clinical Trials Review, H1, 2021
GlobalData's clinical trial report, “Hyperinsulinemia - Global Clinical Trials Review, H1, 2021" provides an overview of Hyperinsulinemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperinsulinemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for...
-
Sector Analysis
Dyslipidemia - Competitive Landscape in 2021
In dyslipidemia 3 hydroxy 3 methylglutaryl coenzyme a (HMG CoA) reductase is a major focus of drug developers. There are 155 drugs in the pipeline with 74% molecules present in early stage. Mid-sized Pharma dominates R&D in this indication. The increasing prevalence and preference for newer expensive therapies will drive the market's growth, but delayed diagnosis, low compliance rate, and high preference for low-cost generic products are likely to limit market growth.
-
Product Insights
Diabetic Foot Infection (DFI) Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Diabetic Foot Infection (DFI) Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Diabetic Foot Infection (DFI) Clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Foot Infection (DFI). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points...
-
Product Insights
Diabetic Peripheral Neuropathy Disease - Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Diabetic Peripheral Neuropathy Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Diabetic Peripheral Neuropathy Clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Peripheral Neuropathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor...
-
Sector Analysis
Hypoglycemia - Epidemiology Forecast to 2030
Hypoglycemia is a condition in which a person’s glucose, or blood sugar, level is lower than normal. It most often, although not exclusively, occurs in patients with drug-treated type 1 (T1D) or type 2 diabetes mellitus (T2D), as glucose-lowering medications can lead to hypoglycemia (Silbert et al., 2018). Symptoms of hypoglycemia include fatigue, fast heartbeat, shakiness, anxiety, and hunger. During a severe hypoglycemic episode, symptoms can escalate to blurred vision, confusion, seizures, or even loss of consciousness. In those without...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.